ArticleCureus2025
Anaphylaxis Secondary to Aeroallergen Immunotherapy in a Military Member.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of a 43-year-old active-duty US Air Force service member who experienced an anaphylactic reaction during routine aeroallergen immunotherapy. The patient had a long-standing history of perennial and seasonal allergic rhinoconjunctivitis, with confirmed sensitization to multiple environmental allergens through skin prick and serum-specific IgE testing. He tolerated build-up immunotherapy until reaching the 0.4 mL injections from the maintenance 1:1 volume/volume (1:100 weight/volume) vials, at which point he developed an anaphylactic reaction characterized by vomiting, hypotension, and respiratory distress. He required three intramuscular doses of epinephrine and was transferred to the emergency department. This case underscores the complexities of allergy management in military personnel, particularly those receiving immunotherapy in preparation for deployment. The patient's severe systemic reaction raises important considerations regarding risk stratification, protocol modification, and implications for operational readiness. Although he was deemed fit for duty after stabilization, this event highlights how environmental allergen exposure and immunotherapy-related complications can impact force health protection. Proactive allergy screening, patient education, and emergency preparedness, especially ensuring access to and proper use of epinephrine auto-injectors, remain essential components of pre-deployment medical planning. This case reinforces the importance of individualized immunotherapy protocols, vigilant monitoring for systemic reactions, and comprehensive contingency planning within military healthcare systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.